Harmony Biosciences (HRMY) Announces FDA Grants Priority Review for Application For Wakix (Pitolisant) In Pediatric Narcolepsy

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/13/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. MSFT
9. CRM
10. CRWV

Go back to Harmony Biosciences (HRMY) Announces FDA Grants Priority Review for Application For Wakix (Pitolisant) In Pediatric Narcolepsy
Harmony Metals, Inc. Common (NASDAQ: HRMY) Delayed: 34.46 -0.74 (2.1%)
Previous Close $35.20    52 Week High $1.35 
Open $35.20    52 Week Low $0.10 
Day High $35.71    P/E N/A 
Day Low $34.32    EPS $0.00 
Volume 693,306